Sitemap
October 21, 2011 Articles
Filter by Available Specialty
- 12-month Harbor results show meaningful improvement in BCVA with treatment
- Alcon officials: CIBA integration on schedule
- Artificial tears found to improve vision in patients with dry eye
- Assets and opportunities dominate discussion of ophthalmology 'space'
- Cell proliferation may be responsible for CD4 T-cell level maintenance in elite controllers
- Clinicians debate consecutive vs. simultaneous crosslinking, PRK
- FDA encourages ophthalmic product sponsors to start with human testing in U.S.
- FDA offers tips for getting ophthalmic innovations to market
- FDA updates potential CNS adverse reaction reports for linezolid, methylene blue
- FDA, CMS parallel review process a 'game changer'
- Flu vaccine accepted by pregnant women, not linked to miscarriage
- Heidelberg releases new software for Spectralis
- HHS announces new incentives for providers to coordinate care through ACOs
- Improved staining, dyes assist ILM peeling
- Iridex introduces MicroPulse module to green laser system
- Lanx forms surgeon advisory board
- Multiple joint osteoarthritis poses greater risk for African-American men and women
- New formulations of testosterone transdermal system approved by FDA
- New treatment for hyperopic presbyopes safe, effective, study shows
- Nine IV compounds in development for resistant gram-negative bacilli
- Patients on iron chelator show improvement in liver fibrosis after 3 years
- Pneumococcal vaccine decreases by 100% IPD caused by vaccine serotypes
- Public restrooms contained too many bacteria to count
- Research ongoing to find improved influenza vaccine
- Rotavirus decreased in adults after widespread vaccination among children
- RTVue receives 510(k) clearance for measurements of corneal power, curvature and thickness
- Study finds no cause for delaying hip fracture surgery in patients receiving antiplatelet drugs
- SWOG S9430: Complete surgical resection associated with prolonged OS in stage IV melanoma
- Update on the EORTC 18991 trial with pegylated interferon
- Vistakon studies' findings tout benefits of lenses
- What is the optimal adjuvant interferon therapy for melanoma?